RCT in 250 patients with newly diagnosed bipolar disorder (240 analysed): add-on low-dose aspirin 150 mg did not reduce mood instability at 6 months vs placebo (difference 0.022, p=0.58), with no benefit on secondary or tertiary outcomes.
RCTn = 250
Bruun et al. No Effect of Low-Dose Aspirin Versus Placebo as Add-On Treatment in Bipolar Disorder-Results From a Randomised Controlled Trial (the A-Bipolar RCT)